Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
50%(3 trials)

Phase Distribution

Ph phase_4
1
17%
Ph phase_2
1
17%
Ph phase_3
4
67%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
4(66.7%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 34 (66.7%)
Phase 41 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

The RCT of Acupuncture on PCOS Combined With IR

NCT02491333
completedphase_4

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

NCT01490918
completedphase_3

PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

NCT01999686
completedphase_3

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

NCT01204775
completedphase_3

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

NCT00121667
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02491333Phase 3

The RCT of Acupuncture on PCOS Combined With IR

Completed
NCT01490918Phase 4

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

Completed
NCT01999686Phase 3

PCOS Treatment Using DLBS3233, Metformin, and Combination of Both

Completed
NCT01204775Phase 3

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Completed
NCT00121667Phase 3

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

Completed
NCT01969318Phase 2

Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6